Close Menu

People in the News

Premium

Gary Gilliland has taken on two posts at Merck, including vice president of Merck Research Laboratories and franchise head of oncology.

Gilliland is a Harvard Medical School professor and a Howard Hughes Medical Institute investigator. He is also director for the Leukemia Program at the Dana Farber/Harvard Medical Cancer Center and director of the Cancer Stem Cell Program at the Harvard Stem Cell Institute.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers in France have explored the genetic history of the blue cheese mold, Forbes reports.

The South China Morning Post reports eight genetic testing firms in Hong Kong are under scrutiny for potentially misleading consumers.

In Science this week: platform to diagnose genetic disease in children, lung disease-causing genetic mutation corrected in mice, and more.

Wired reports on how genetic genealogy's use in forensics has exploded in the year since an arrest in the Golden State Killer case was made.

Apr
30
Sponsored by
Lexogen

This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.

May
21
Sponsored by
Qiagen

This webinar will provide a first-hand look at how a hematology/oncology lab in the UK set up and validated three molecular assays for routine in-house use.